1.
Tsumura A, Looi D, Moskoff BN, Tuscano JM, Esteghamat N. Outcomes of Gemcitabine, Vinorelbine, and Doxorubicin in Peripheral T-Cell Lymphoma. acmcr [Internet]. 2024 May 7 [cited 2026 Jun. 15];8(3):92-6. Available from: https://fortunejournals.org/ojs/index.php/acmcr/article/view/22941